Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04536935 · ClinicalTrials.gov registry record · NA
Mobile Mental Health Apps for Suicide Prevention
A NA study of Depression and Anxiety, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 838
- Enrollment target
- 1
- Study location
NCT04536935: Completed NA study of Depression and Anxiety, sponsored by University of Washington.
NCT04536935 is a NA study of Depression and Anxiety that has completed, run by University of Washington. The registered enrollment target is 838 participants, roughly in line with the 785-participant average among 679 other Depression trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04536935, a NA study of Depression and Anxiety, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 838 participants
- Enrollment target
- 1
- Study location
Study Summary
Access to mental health care by essential workers and the unemployed during the COVID19 pandemic has been challenging. Usual access to mental health care is limited by social distancing, and for many now unemployed due to closures of businesses, insurance is insufficient to cover the costs of mental health care. For these individuals who are at risk for suicide (isolation, unemployment, financial crisis plus past suicide attempts, significant mental health challenges), access to care is crucial and many maybe turning to online and accessible interventions, such as mental health apps and other online resources. Indeed, organizations such as the VA have already created free access mobile applications for mental health in anticipation of this need. Using Psyberguide, the investigators will identify the top ten free apps that address mental health issues and conduct a nation-wide evaluation of these apps with participants who are essential workers and unemployed with risk for suicide. Participants will first be surveyed about which strategies they have used to manage mental health issues, what apps and online tools they have used, and what usability challenges they have faced. The investigators will then ask a random sample of participant to engage in a randomized trial of these top-rated apps for 4 weeks. Apps will be rated on usability, acceptability, feasibility and effectiveness. Results from this trial will be quickly disseminated through several avenues: (1) the UWAC website and ALACRITY Centers network; (2) through CREATIV Lab's partnership with Mental Health America; (3) through the UW Center for Suicide Prevention and Recovery (CSPAR) and partnerships with other suicide focused organizations including Forefront, the American Foundation for Suicide Prevention, that American Association of Suicidology, the Rocky Mountain MIRECC, and the Defense Suicide Prevention Office and (4) through local partnership with King County and WA state contact tracers.
Primary Outcome
The Patient Health Questionnaire (PHQ-9) consists of 9 depression items and one disability item. Each item is associated with a DSM symptom of depression, which the participant rates whether or not they have experienced the symptom over the last two weeks, with severity rating of 0-3. It is one of the few measures that is brief (it takes less than one minute to give) and has been found to have excellent sensitivity to change over time, with a total sum score ranging from 0 - 27. Higher scores in
Conditions Studied
Interventions
- BEHAVIORAL Mobile Mental Health App - 1
- BEHAVIORAL Mobile Mental Health App - 2
- BEHAVIORAL Mobile Mental Health App - 3
- BEHAVIORAL Mobile Mental Health App - 4
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 838 participants |
| Start Date | 2020-11-30 |
| Est. Completion | 2021-06-20 |
| Phase | NA |
What the finished NCT04536935 record still lists
NCT04536935 is an interventional study that assigns participants to a tested intervention. The registered 838 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 785-participant average among 679 other Depression trials with a reported enrollment target.
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 4 interventions - of which Mobile Mental Health App - 1 is the first listed.
NCT04536935 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT04536935 about?
NCT04536935 is a clinical study titled "Mobile Mental Health Apps for Suicide Prevention". Access to mental health care by essential workers and the unemployed during the COVID19 pandemic has been challenging. Usual access to mental health care is limited by social distancing, and for many now unemployed due to closures of businesses, insurance is insufficient to cover the costs of mental...
What is the current status of trial NCT04536935?
This trial is currently completed. It is a NA study. The enrollment target is 838 participants. The study started on 2020-11-30. Estimated completion is 2021-06-20.
What conditions does trial NCT04536935 study?
This clinical trial studies the following conditions: Depression, Anxiety, Emotional Regulation.
What interventions are being tested in trial NCT04536935?
The interventions under investigation include: Mobile Mental Health App - 1 (BEHAVIORAL), Mobile Mental Health App - 2 (BEHAVIORAL), Mobile Mental Health App - 3 (BEHAVIORAL), Mobile Mental Health App - 4 (BEHAVIORAL).
Who is sponsoring clinical trial NCT04536935?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04536935 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04536935's enrollment target sits among peer trials
838 49th of 679 higher than 631 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422550 · 837 participants
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment
- NCT04831580 · 840 participants · NA
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- NCT04976881 · 840 participants · NA
Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
- NCT04985903 · 840 participants · NA
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy